ask="3.39"
ask_size="500"
average_daily_volume="442428"
bid="1.60"
bid_size="200"
book_value="0.44"
change="-0.08"
change_from_200_day_moving_average="1.19"
change_from_50_day_moving_average="1.06"
change_from_52_week_high="-0.23"
change_From_52_week_low="2.13"
change_in_percent="-2.48%"
close="3.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="21827000"
high="3.37"
high_52_weeks="3.38"
last_trade_date="2/21/2017"
last_trade_price="3.15"
last_trade_size="2228"
last_trade_time="4:00pm"
low="2.77"
low_52_weeks="1.02"
market_capitalization="73.86M"
moving_average_200_day="1.96"
moving_average_50_day="2.09"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="3.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+61.05%"
percent_change_from_50_day_moving_average="+50.95%"
percent_change_from_52_week_high="-6.91%"
percent_change_from_52_week_low="+208.82%"
previous_close="3.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.41"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="CBAY"
volume="1171322"
weeks_range_52="1.02 - 3.38"
